{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:27:32Z","timestamp":1774438052400,"version":"3.50.1"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2015,9,25]],"date-time":"2015-09-25T00:00:00Z","timestamp":1443139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0138732","type":"journal-article","created":{"date-parts":[[2015,9,25]],"date-time":"2015-09-25T18:40:42Z","timestamp":1443206442000},"page":"e0138732","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Hemodynamic Effects of the Non-Peptidic Angiotensin-(1-7) Agonist AVE0991 in Liver Cirrhosis"],"prefix":"10.1371","volume":"10","author":[{"given":"Sabine","family":"Klein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandana B.","family":"Herath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Schierwagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josephine","family":"Grace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Haltenhof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank E.","family":"Uschner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian P.","family":"Strassburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tilman","family":"Sauerbruch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Walther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter W.","family":"Angus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonel","family":"Trebicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,9,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1053\/j.gastro.2013.06.036","article-title":"Activation of the MAS receptor by angiotensin-(1\u20137) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis","volume":"145","author":"JA Grace","year":"2013","journal-title":"Gastroenterology"},{"key":"ref2","article-title":"Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis","author":"M Granzow","year":"2014","journal-title":"Hepatology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1136\/gut.2007.144584","article-title":"Mechanisms of extrahepatic vasodilation in portal hypertension","volume":"57","author":"M Hennenberg","year":"2008","journal-title":"Gut"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1042\/CS20120030","article-title":"Update on new aspects of the renin-angiotensin system in liver disease: clinical implications and new therapeutic options","volume":"123","author":"JA Grace","year":"2012","journal-title":"Clin Sci"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"R Bataller","year":"2005","journal-title":"J Clin Invest"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1046\/j.1365-2362.2003.01251.x","article-title":"Acute haemodynamic effects of losartan in anaesthetized cirrhotic rats","volume":"33","author":"J Heller","year":"2003","journal-title":"Eur J Clin Invest"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1478-3231.2005.01053.x","article-title":"Vascular, hemodynamic and renal effects of low-dose losartan in rats with secondary biliary cirrhosis","volume":"25","author":"J Heller","year":"2005","journal-title":"Liver Int"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"G147","DOI":"10.1152\/ajpgi.00462.2007","article-title":"Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver","volume":"296","author":"M Moreno","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/CS20080647","article-title":"Angiotensin-(1\u20137), an alternative metabolite of the renin-angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat","volume":"117","author":"JS Lubel","year":"2009","journal-title":"Clin Sci"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.peptides.2006.10.007","article-title":"Evidence for a new angiotensin-(1\u20137) receptor subtype in the aorta of Sprague-Dawley rats","volume":"28","author":"DMR Silva","year":"2007","journal-title":"Peptides"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/01.HYP.0000037979.53963.8F","article-title":"AVE 0991, a nonpeptide mimic of the effects of angiotensin-(1\u20137) on the endothelium","volume":"40","author":"G Wiemer","year":"2002","journal-title":"Hypertension"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"G99","DOI":"10.1152\/ajpgi.00163.2012","article-title":"Angiotensin-(1\u20137) reduces the perfusion pressure response to angiotensin II and methoxamine via an endothelial nitric oxide-mediated pathway in cirrhotic rat liver","volume":"304","author":"CB Herath","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/CS20110036","article-title":"Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors","volume":"121","author":"S Bosnyak","year":"2011","journal-title":"Clin Sci"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1177\/1470320311435534","article-title":"Possible mechanism of the cardio-renal protective effects of AVE-0991, a non-peptide Mas-receptor agonist, in diabetic rats","volume":"13","author":"K Singh","year":"2012","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1527-3466.2006.00239.x","article-title":"Pharmacological effects of AVE 0991, a nonpeptide angiotensin-(1\u20137) receptor agonist","volume":"24","author":"RAS Santos","year":"2006","journal-title":"Cardiovasc Drug Rev"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"808726","DOI":"10.1155\/2012\/808726","article-title":"Renoprotective Effects of AVE0991, a Nonpeptide Mas Receptor Agonist, in Experimental Acute Renal Injury","volume":"2012","author":"LC Barroso","year":"2012","journal-title":"Int J Hypertens"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1161\/01.HYP.0000141438.64887.42","article-title":"Nonpeptide AVE 0991 is an angiotensin-(1\u20137) receptor Mas agonist in the mouse kidney","volume":"44","author":"SVB Pinheiro","year":"2004","journal-title":"Hypertension"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1016\/j.bbapap.2013.08.008","article-title":"The influence of angiotensin-(1\u20137) Mas receptor agonist (AVE 0991) on mitochondrial proteome in kidneys of apoE knockout mice","volume":"1834","author":"M Suski","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/bph.12318","article-title":"AVE 0991, a non-peptide mimic of angiotensin-(1\u20137) effects, attenuates pulmonary remodelling in a model of chronic asthma","volume":"170","author":"MG Rodrigues-Machado","year":"2013","journal-title":"Br J Pharmacol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/hep.21673","article-title":"Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA\/Rho-kinase and activation of endothelial nitric oxide synthase","volume":"46","author":"J Trebicka","year":"2007","journal-title":"Hepatology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1002\/hep.23222","article-title":"Role of beta3-adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis","volume":"50","author":"J Trebicka","year":"2009","journal-title":"Hepatology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.jhep.2012.07.033","article-title":"HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects","volume":"57","author":"S Klein","year":"2012","journal-title":"J Hepatol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/hep.22170","article-title":"Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic rats","volume":"47","author":"J Trebicka","year":"2008","journal-title":"Hepatology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"G98","DOI":"10.1152\/ajpgi.00045.2009","article-title":"Portal pressure responses and angiotensin peptide production in rat liver are determined by relative activity of ACE and ACE2","volume":"297","author":"CB Herath","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1096\/fj.00-0797fje","article-title":"Alcohol consumption is controlled by angiotensin II","volume":"15","author":"B Maul","year":"2001","journal-title":"FASEB J"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase","volume":"277","author":"C Vickers","year":"2002","journal-title":"J Biol Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jhep.2010.04.025","article-title":"Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells","volume":"53","author":"J Trebicka","year":"2010","journal-title":"J Hepatol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0676.1990.tb00428.x","article-title":"Sirius red histophotometry and spectrophotometry of sections in the assessment of the collagen content of liver tissue and its application in growing rat liver","volume":"10","author":"J James","year":"1990","journal-title":"Liver"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0016-5085(99)70461-0","article-title":"Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas","volume":"117","author":"H Miyoshi","year":"1999","journal-title":"Gastroenterology"},{"key":"ref30","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/958298","article-title":"AVE0991, a Nonpeptide Compound, Attenuates Angiotensin II-Induced Vascular Smooth Muscle Cell Proliferation via Induction of Heme Oxygenase-1 and Downregulation of p-38 MAPK Phosphorylation","volume":"2012","author":"C Sheng-Long","year":"2012","journal-title":"Int J Hypertens"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/01.fjc.0000175237.41573.63","article-title":"The endothelium-dependent vasodilator effect of the nonpeptide Ang(1\u20137) mimic AVE 0991 is abolished in the aorta of mas-knockout mice","volume":"46","author":"VS Lemos","year":"2005","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"H1113","DOI":"10.1152\/ajpheart.00828.2006","article-title":"The nonpeptide angiotensin-(1\u20137) receptor Mas agonist AVE-0991 attenuates heart failure induced by myocardial infarction","volume":"292","author":"AJ Ferreira","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1161\/01.HYP.38.3.665","article-title":"Angiotensin-(1\u20137): Cardioprotective Effect in Myocardial Ischemia\/Reperfusion","volume":"38","author":"AJ Ferreira","year":"2001","journal-title":"Hypertension"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jhep.2007.03.008","article-title":"Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1\u20137) levels in experimental biliary fibrosis","volume":"47","author":"CB Herath","year":"2007","journal-title":"J Hepatol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1124\/dmd.111.042689","article-title":"Metabolism and pharmacokinetics of morinidazole in humans: identification of diastereoisomeric morpholine N+-glucuronides catalyzed by UDP glucuronosyltransferase 1A9","volume":"40","author":"R Gao","year":"2012","journal-title":"Drug Metab Dispos"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0138732","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T00:04:22Z","timestamp":1567209862000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0138732"}},"subtitle":[],"editor":[{"given":"Matias A","family":"Avila","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,9,25]]},"references-count":35,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,9,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0138732","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,25]]}}}